Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DanGene Biotech is a molecular diagnostics company headquartered in Wuhan, China, that specializes in the development and manufacture of in vitro diagnostic (IVD) reagents and automated equipment. The company's core technology revolves around real-time PCR and nucleic acid extraction, providing solutions for infectious disease monitoring, oncology screening, and genetic health. Their product portfolio includes widely used kits for Human Papillomavirus (HPV) genotyping, hepatitis virus quantification, and respiratory pathogen detection. DanGene operates high-standard GMP manufacturing facilities and serves a broad network of clinical laboratories and hospitals. The company is a key player in the Chinese diagnostic market, particularly in the field of women's health and infectious disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dangene.